摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-levulinoyloxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate | 351530-31-9

中文名称
——
中文别名
——
英文名称
methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-levulinoyloxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate
英文别名
——
methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-levulinoyloxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate化学式
CAS
351530-31-9
化学式
C58H69NO18
mdl
——
分子量
1068.18
InChiKey
YCVIVEIFPYGJLE-CVCZBDOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.41
  • 重原子数:
    77.0
  • 可旋转键数:
    25.0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    225.21
  • 氢给体数:
    1.0
  • 氢受体数:
    18.0

反应信息

  • 作为反应物:
    描述:
    methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-levulinoyloxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate乙酸肼 作用下, 以 乙醇甲苯 为溶剂, 反应 3.0h, 以95%的产率得到methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-hydroxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate
    参考文献:
    名称:
    Synthesis of linear-type chondroitin clusters having a C8 spacer between disaccharide moieties and enzymatic transfer of d-glucuronic acid to the artificial glycans
    摘要:
    Newly designed linear-type glycoclusters were synthesized which involve a chondroitin repeating disaccharide ligand and a hydrophobic octyl ether spacer. The spacer mimics the corresponding disaccharide unit. Repeating elongation of the pseudo-tetrasaccharide that was derived from the common cluster unit [--> 8)-octyl-(1 --> 3)-beta -D-Gal-NAc-(1 --> 4)-beta -D-GlcA-(1 -->] allowed the syntheses of up to the pseudo-decasaccharide analog of chondroitin. An enzymatic D-GlcA transfer at the non-reducing end of the synthesized artificial glycans by GlcATase II was observed. (C) 2001 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0008-6215(01)00071-4
  • 作为产物:
    描述:
    4-methoxyphenyl O-[2-azido-4,6-O-benzylidene-2-deoxy-3-O-(8-hydroxyoctyl)-β-D-galactopyranosyl]-(1->4)-6-O-tert-butyldiphenylsilyl-2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranoside 在 Lindlar's catalyst 吡啶4-二甲氨基吡啶sodium chlorite2-甲基-2-丁烯草酰氯四丁基氟化铵氢气二甲基亚砜N,N-二异丙基乙胺 作用下, 以 四氢呋喃吡啶甲醇正己烷二氯甲烷乙酸乙酯1,2-二氯乙烷甲苯叔丁醇 为溶剂, 反应 103.08h, 生成 methyl [2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(8-levulinoyloxyoctyl)-β-D-galactopyranosyl]-(1->4)-[4-methoxyphenyl 2,3-di-O-(4-methylbenzoyl)-β-D-glucopyranosid]uronate
    参考文献:
    名称:
    Synthesis of linear-type chondroitin clusters having a C8 spacer between disaccharide moieties and enzymatic transfer of d-glucuronic acid to the artificial glycans
    摘要:
    Newly designed linear-type glycoclusters were synthesized which involve a chondroitin repeating disaccharide ligand and a hydrophobic octyl ether spacer. The spacer mimics the corresponding disaccharide unit. Repeating elongation of the pseudo-tetrasaccharide that was derived from the common cluster unit [--> 8)-octyl-(1 --> 3)-beta -D-Gal-NAc-(1 --> 4)-beta -D-GlcA-(1 -->] allowed the syntheses of up to the pseudo-decasaccharide analog of chondroitin. An enzymatic D-GlcA transfer at the non-reducing end of the synthesized artificial glycans by GlcATase II was observed. (C) 2001 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0008-6215(01)00071-4
点击查看最新优质反应信息